ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 166 filers reported holding ALLAKOS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,786,618 | -46.9% | 787,056 | +1.9% | 0.22% | -59.9% |
| Q2 2023 | $3,366,321 | +34.6% | 772,092 | +202.3% | 0.54% | +43.7% |
| Q4 2021 | $2,501,000 | -89.2% | 255,400 | +16.2% | 0.37% | -77.2% |
| Q3 2021 | $23,261,000 | +80.6% | 219,726 | +45.6% | 1.64% | +57.3% |
| Q2 2021 | $12,882,000 | -0.1% | 150,900 | +34.3% | 1.04% | +139.9% |
| Q1 2021 | $12,901,000 | +57.0% | 112,400 | +91.5% | 0.43% | +19.9% |
| Q4 2020 | $8,218,000 | +168.8% | 58,700 | +38.0% | 0.36% | +49.0% |
| Q2 2020 | $3,057,000 | +14.5% | 42,536 | -29.1% | 0.24% | +21.5% |
| Q1 2020 | $2,670,000 | -82.4% | 60,000 | -62.2% | 0.20% | -91.9% |
| Q4 2019 | $15,143,000 | – | 158,800 | – | 2.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |